bioAffinity Technologies (BIAFW) Preferred Stock Liabilities (2021)

bioAffinity Technologies (BIAFW) reported Preferred Stock Liabilities of $4.0 million for Q4 2021.

bioAffinity Technologies (BIAFW) Preferred Stock Liabilities (2021) Analysis & Trends

bioAffinity Technologies (BIAFW) has 1 years of Preferred Stock Liabilities data on file, last reported at $4.0 million in Q4 2021.

  • Preferred Stock Liabilities for Q4 2021 came in at $4.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was $4.0 million (changed N/A YoY), and the FY2021 annual result was $4.0 million, changed N/A from the prior year.
  • Preferred Stock Liabilities steadied at $4.0 million in Q4 2021 per BIAFW's latest filing.
  • Over five years, Preferred Stock Liabilities peaked at $4.0 million in Q4 2021 and troughed at $4.0 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Waters 30,529.42 Bn 30,528.96 Bn 1.11 Bn -
2 Thermo Fisher Scientific 183.75 Bn 180.50 Bn 7.74 Bn -
3 Danaher 133.13 Bn 127.43 Bn 3.59 Bn -
4 Idexx Laboratories 46.14 Bn 45.94 Bn 722.74 Mn -
5 Agilent Technologies 38.20 Bn 36.39 Bn 990.00 Mn -
6 Natera 31.50 Bn 30.40 Bn 696.04 Mn -
7 Iqvia Holdings 31.34 Bn 29.36 Bn 1.36 Bn -
8 Illumina 24.51 Bn 23.36 Bn 721.00 Mn -
9 Mettler Toledo International 23.53 Bn 23.47 Bn 555.82 Mn -
10 bioAffinity Technologies - - - -

Historic Data

Download Data
DateValue
Dec 31, 2021 4.04 Mn